𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical trial of the safety and immunogenicity of three doses of a leishmania vaccine

✍ Scribed by Firooz, Alireza; Alimohammadian, Mohammad H.; Khamesipour, Ali; Dowlati, Yahya

Book ID
121897608
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
152 KB
Volume
16
Category
Article
ISSN
0923-1811

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Single dose inactivated hepatitis A vacc
Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity
✍ Dr. P. van Damme; C. MatheΓ―; S. Thoelen; A. Meheus; A. Safary; F. E. AndrΓ© πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 537 KB

## Abstract In comparison with the classical immunisation schedules (0‐1‐6 or 0‐1‐12 months) for hepatitis A, a 0‐ and 12‐ or a 0‐ and 6‐month schedule would have important advantages by reducing the number of injections and discomfort and increasing scheduling convenience and patient compliance. I

Safety and immunogenicity of a killed Le
Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial
✍ Ivan Dario VΓ©lez; Sonia del Pilar Agudelo; Maria Patricia Arbelaez; Katherine Gi πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier Science 🌐 English βš– 699 KB

The safety and immunogenicity of an intramuscular (i.m.) and intradermal (ID) formulation of autoclaved Leishmania (Leishmania) amazonensis vaccine was evaluated in 296 volunteers in a randomized, placebo-controlled, double-blind trial in Colombia. There were 4 vaccination groups: i.m. vaccine, i.m.